Join
Live feed
·
PRReleasevia Quantisnow
Ocuphire Pharma Inc. logo

Ocuphire Announces Positive Topline Results from MIRA-3 Phase 3 FDA Registration Trial for Nyxol® in the Reversal of Mydriasis

ByQuantisnow·Wall Street's wire, on your screen.
OCUP· Ocuphire Pharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OCUP (Ocuphire Pharma Inc.) and more on Quantisnow.